the limitations of current standards of care for hodgkin lymphoma
Published 2 years ago • 71 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
5:12
the current standard of care in advanced stage hl
-
2:42
the current role of chemotherapy in the treatment of hodgkin lymphoma & the impact of novel agents
-
2:03
novel therapeutic agents in the treatment of hodgkin and non-hodgkin lymphoma
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
1:29
updates on the diagnosis, risk stratification and management of hl
-
10:55
what is low-grade non-hodgkin lymphoma?
-
11:24
when your child has lymphoma: laura’s story
-
39:31
nf 100 e71 | lymphoma mnemonics | dr. nikita nanwani
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
1:27
diagnosis and risk stratification in hodgkin lymphoma: updates and novel approaches
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
1:37
the role of ctdna in hodgkin lymphoma
-
1:03
what’s on the horizon for hodgkin lymphoma?
-
1:09
novel immunotherapy combinations in hodgkin lymphoma
-
2:40
exploring the genomic landscape of hodgkin lymphoma with whole-genome sequencing
-
1:17
the importance of risk-adapted therapies in hodgkin lymphoma
-
3:36
the real cost of hematological cancer care explained
-
1:37
a prospective trial of radiation-free chemotherapy in high- and low-risk hl
-
5:29
developing new prognostic scores in hodgkin lymphoma
-
2:19
gemcitabine and bendamustine as a salvage regimen for recurrent/refractory hodgkin lymphoma
-
1:59
hodgkin lymphoma: prognostic markers in the era of novel treatments
-
2:19
novel treatment options for non-hodgkin lymphoma